Equities
Health CareMedical Equipment and Services
  • Price (DKK)139.05
  • Today's Change5.45 / 4.08%
  • Shares traded1.29m
  • 1 Year change+16.12%
  • Beta1.1372
Data delayed at least 15 minutes, as of Nov 08 2024 15:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year GN Store Nord A/S's revenues fell -3.03% from 18.69bn to 18.12bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 511.00m to 228.00m, a -55.38% decrease.
Gross margin52.18%
Net profit margin3.91%
Operating margin7.96%
Return on assets2.33%
Return on equity6.61%
Return on investment3.97%
More ▼

Cash flow in DKKView more

In 2023, GN Store Nord A/S increased its cash reserves by 118.38%, or 1.17bn. The company earned 2.64bn from its operations for a Cash Flow Margin of 14.56%. In addition the company used 1.14bn on investing activities and also paid 312.00m in financing cash flows.
Cash flow per share16.31
Price/Cash flow per share8.84
Book value per share69.96
Tangible book value per share-45.43
More ▼

Balance sheet in DKKView more

GN Store Nord A/S has a Debt to Total Capital ratio of 53.16%, a lower figure than the previous year's 79.82%.
Current ratio0.6881
Quick ratio0.4532
Total debt/total equity1.14
Total debt/total capital0.5316
More ▼

Growth rates in DKK

Year on year, growth in earnings per share excluding extraordinary items dropped -58.87%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.29%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-29.07
EPS (TTM) vs
TTM 1 year ago
35.67
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.